GlassScriptPhysician profile
Balvinder Bharj
NPI 1871967356
$7,205.30
in general payments reported to CMS, 2019-2025
12 companies · $1,500 in 2025
The $1,500 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,575 · 2020: $542 · 2021: $484 · 2022: $661 · 2023: $173 · 2024: $2,270 · 2025: $1,500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,924 · Travel and Lodging: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,924.46 |
| Travel and Lodging | $1,018.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $4,380.26 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $661.59 | 2024-2025 | Infuse, Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $535.90 | 2024-2025 | Xdemvy |
| Coopervision INC. | $479.13 | 2024-2025 | Misight Contact Lens, Ortho-K Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $352.61 | 2021-2025 | Precision 1, Dailies Total1, Total30 |
| Sun Pharmaceutical Industries INC. | $174.72 | 2020-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $138.99 | 2025 | Catalys System |
| Harrow Eye, LLC | $124.39 | 2025 | Vevye |
| Aerie Pharmaceuticals, INC. | $122.24 | 2019 | |
| Abbvie INC. | $120.00 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $96.07 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Balvinder Bharj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.